XML 64 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisitions and Investments in Unconsolidated Affiliates (Narrative) (Details) (USD $)
3 Months Ended 6 Months Ended 6 Months Ended 0 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Dec. 31, 2013
Jun. 30, 2014
Minimum [Member]
Jun. 30, 2014
Maximum [Member]
Jun. 30, 2014
Controlling Interest [Member]
center
Jun. 30, 2013
Controlling Interest [Member]
center
Sep. 01, 2011
National Surgical Care, Inc. [Member]
center
Jun. 30, 2013
National Surgical Care, Inc. [Member]
Jun. 30, 2014
Sheridan Healthcare [Member]
Jun. 30, 2014
Sheridan Healthcare [Member]
Jun. 30, 2014
Joint Venture [Member]
Jun. 30, 2014
Joint Venture [Member]
Jun. 30, 2013
Joint Venture [Member]
Jun. 30, 2014
Joint Venture [Member]
Noncontrolling Interest [Member]
entity
Jun. 30, 2014
Joint Venture [Member]
Controlling Interest [Member]
center
Jun. 30, 2013
Joint Venture [Member]
Controlling Interest [Member]
center
Business Acquisition [Line Items]                                      
Number of business acquisitions               2 2 17                  
Payments to Acquire Businesses, Net of Cash Acquired     $ 24,437,000 $ 18,346,000                       $ 252,000      
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High                   7,500,000                  
Contingent Purchase Price Obligation, Settlement Amount                     2,744,000                
Goodwill deductible for tax purposes 25,059,000 17,469,000 25,059,000 17,469,000                              
Other operating expenses in acquisition related costs, primarily attorney fees                       3,600,000 3,600,000            
Proceeds from Divestiture of Interest in Consolidated Subsidiaries                             1,700,000        
Number Of Joint Venture Entities Acquired                                 3    
Number Of Consolidated Centers Contributed To Joint Venture                                   4 1
Equity Method Investments 26,546,000   26,546,000   16,392,000                 6,534,000 6,534,000 5,200,000      
Gain (loss) on deconsolidation $ 1,366,000 $ 0 $ 3,411,000 $ 2,237,000                   $ 1,366,000 $ 3,411,000 $ 2,237,000      
Estimated Probability Of Fair Value Variables Range           5.00% 35.00%